Cargando…
Survival Function of Clinical and Radiographic Success of Three Obturating Materials in Primary Teeth at 3, 6 and 9 Months Periodic Intervals - A Randomized Controlled Clinical Trial
The study aims to assess clinically and radiographically the success of zinc oxide eugenol, metapex, and endoflas as root canal obturating materials in primary teeth over 3, 6, and 9 months of time intervals. The randomized controlled trial was performed in 60 primary molars of 36 children aged betw...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer - Medknow
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10466600/ https://www.ncbi.nlm.nih.gov/pubmed/37654309 http://dx.doi.org/10.4103/jpbs.jpbs_579_22 |
_version_ | 1785098921477931008 |
---|---|
author | Kumar, Kandaswamy Saravana Asokan, Sharath Geethapriya, PR Sivakumar, Kailasam Yamunadevi, Andamuthu |
author_facet | Kumar, Kandaswamy Saravana Asokan, Sharath Geethapriya, PR Sivakumar, Kailasam Yamunadevi, Andamuthu |
author_sort | Kumar, Kandaswamy Saravana |
collection | PubMed |
description | The study aims to assess clinically and radiographically the success of zinc oxide eugenol, metapex, and endoflas as root canal obturating materials in primary teeth over 3, 6, and 9 months of time intervals. The randomized controlled trial was performed in 60 primary molars of 36 children aged between 4 and 9 years. Permanent restorations were given and stainless steel crowns were placed for the treated tooth. Comparing the survival proportion between the three groups was done using the Wilcoxon (Gehans) statistical test. The clinical survival variable showed 100% survival proportion for zinc oxide eugenol and endoflas, while for metapex it was 69% at the end of 9 months. The radiographical survival proportion was 100% for zinc oxide eugenol, followed by endoflas at 92% and 58% for metapex group. |
format | Online Article Text |
id | pubmed-10466600 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Wolters Kluwer - Medknow |
record_format | MEDLINE/PubMed |
spelling | pubmed-104666002023-08-31 Survival Function of Clinical and Radiographic Success of Three Obturating Materials in Primary Teeth at 3, 6 and 9 Months Periodic Intervals - A Randomized Controlled Clinical Trial Kumar, Kandaswamy Saravana Asokan, Sharath Geethapriya, PR Sivakumar, Kailasam Yamunadevi, Andamuthu J Pharm Bioallied Sci Original Article The study aims to assess clinically and radiographically the success of zinc oxide eugenol, metapex, and endoflas as root canal obturating materials in primary teeth over 3, 6, and 9 months of time intervals. The randomized controlled trial was performed in 60 primary molars of 36 children aged between 4 and 9 years. Permanent restorations were given and stainless steel crowns were placed for the treated tooth. Comparing the survival proportion between the three groups was done using the Wilcoxon (Gehans) statistical test. The clinical survival variable showed 100% survival proportion for zinc oxide eugenol and endoflas, while for metapex it was 69% at the end of 9 months. The radiographical survival proportion was 100% for zinc oxide eugenol, followed by endoflas at 92% and 58% for metapex group. Wolters Kluwer - Medknow 2023-07 2023-07-05 /pmc/articles/PMC10466600/ /pubmed/37654309 http://dx.doi.org/10.4103/jpbs.jpbs_579_22 Text en Copyright: © 2023 Journal of Pharmacy and Bioallied Sciences https://creativecommons.org/licenses/by-nc-sa/4.0/This is an open access journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms. |
spellingShingle | Original Article Kumar, Kandaswamy Saravana Asokan, Sharath Geethapriya, PR Sivakumar, Kailasam Yamunadevi, Andamuthu Survival Function of Clinical and Radiographic Success of Three Obturating Materials in Primary Teeth at 3, 6 and 9 Months Periodic Intervals - A Randomized Controlled Clinical Trial |
title | Survival Function of Clinical and Radiographic Success of Three Obturating Materials in Primary Teeth at 3, 6 and 9 Months Periodic Intervals - A Randomized Controlled Clinical Trial |
title_full | Survival Function of Clinical and Radiographic Success of Three Obturating Materials in Primary Teeth at 3, 6 and 9 Months Periodic Intervals - A Randomized Controlled Clinical Trial |
title_fullStr | Survival Function of Clinical and Radiographic Success of Three Obturating Materials in Primary Teeth at 3, 6 and 9 Months Periodic Intervals - A Randomized Controlled Clinical Trial |
title_full_unstemmed | Survival Function of Clinical and Radiographic Success of Three Obturating Materials in Primary Teeth at 3, 6 and 9 Months Periodic Intervals - A Randomized Controlled Clinical Trial |
title_short | Survival Function of Clinical and Radiographic Success of Three Obturating Materials in Primary Teeth at 3, 6 and 9 Months Periodic Intervals - A Randomized Controlled Clinical Trial |
title_sort | survival function of clinical and radiographic success of three obturating materials in primary teeth at 3, 6 and 9 months periodic intervals - a randomized controlled clinical trial |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10466600/ https://www.ncbi.nlm.nih.gov/pubmed/37654309 http://dx.doi.org/10.4103/jpbs.jpbs_579_22 |
work_keys_str_mv | AT kumarkandaswamysaravana survivalfunctionofclinicalandradiographicsuccessofthreeobturatingmaterialsinprimaryteethat36and9monthsperiodicintervalsarandomizedcontrolledclinicaltrial AT asokansharath survivalfunctionofclinicalandradiographicsuccessofthreeobturatingmaterialsinprimaryteethat36and9monthsperiodicintervalsarandomizedcontrolledclinicaltrial AT geethapriyapr survivalfunctionofclinicalandradiographicsuccessofthreeobturatingmaterialsinprimaryteethat36and9monthsperiodicintervalsarandomizedcontrolledclinicaltrial AT sivakumarkailasam survivalfunctionofclinicalandradiographicsuccessofthreeobturatingmaterialsinprimaryteethat36and9monthsperiodicintervalsarandomizedcontrolledclinicaltrial AT yamunadeviandamuthu survivalfunctionofclinicalandradiographicsuccessofthreeobturatingmaterialsinprimaryteethat36and9monthsperiodicintervalsarandomizedcontrolledclinicaltrial |